Trial Profile
Adherence to Therapy in COPD Patients Under Dose Escalation of Roflumilast
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 07 Jan 2014 New trial record